Zhao CH - Search Results

1

[Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer].

Lin L, Xu JM, Wang Y, Ge FJ, Liu LJ, Zhao CH, Li SS, Liu JZ, Li ZQ. Lin L, et al. Among authors: zhao ch. Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):786-90. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21163073 Clinical Trial. Chinese.

2

Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer.

Xu JM, Han Y, Li YM, Zhao CH, Wang Y, Paradiso A. Xu JM, et al. Among authors: zhao ch. BMC Cancer. 2006 Dec 16;6:288. doi: 10.1186/1471-2407-6-288. BMC Cancer. 2006. PMID: 17173694 Free PMC article. Clinical Trial.

3

[Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan].

Xu JM, Li YM, Wang Y, Zhao CH, Yuan SJ, Yang WW, Li ZQ, Han Y, Azzariti A, Paradiso A. Xu JM, et al. Among authors: zhao ch. Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):578-82. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17236550 Chinese.

4

[Cytotoxic effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with oxaliplatin on lung cancer cell line A549].

Zhao CH, Yuan SJ, Wang Y, Ge FJ, Luo WD, Xu JM. Zhao CH, et al. Ai Zheng. 2007 Dec;26(12):1299-303. Ai Zheng. 2007. PMID: 18076790 Free article. Chinese.

5

[HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].

Wang Y, Xu JM, Liu JZ, Lin L, Ge FJ, Li SS, Liu LJ, Zhao CH. Wang Y, et al. Among authors: zhao ch. Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):671-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340047 Chinese.

6

[Clinical analysis of the current treatment status of gastric cancer in 636 patients].

Zhuang QX, Xu JM, Lin L, Ge FJ, Liu LJ, Wang Y, Zhao CH. Zhuang QX, et al. Among authors: zhao ch. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):316-20. doi: 10.3760/cma.j.issn.0253-3766.2012.04.017. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781048 Chinese.

7

Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma.

Chu JS, Ge FJ, Zhang B, Wang Y, Silvestris N, Liu LJ, Zhao CH, Lin L, Brunetti AE, Fu YL, Wang J, Paradiso A, Xu JM. Chu JS, et al. Among authors: zhao ch. J Exp Clin Cancer Res. 2013 Apr 3;32(1):16. doi: 10.1186/1756-9966-32-16. J Exp Clin Cancer Res. 2013. PMID: 23552472 Free PMC article.

8

[Analysis of therapeutic effect and prognosis in patients with metastatic colorectal cancer and different K-ras status].

Ge FJ, Liu JZ, Li SS, Wang Y, Liu LJ, Yao K, Zhao CH, Fu YL, Lin L, Xu JM. Ge FJ, et al. Among authors: zhao ch. Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):273-6. doi: 10.3760/cma.j.issn.0253-3766.2013.04.007. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23985255 Chinese.

9

[Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].

Bai YQ, Liu XJ, Wang Y, Ge FJ, Zhao CH, Fu YL, Lin L, Xu JM. Bai YQ, et al. Among authors: zhao ch. Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):666-71. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24332053 Chinese.

10

Diffuse alveolar hemorrhage after erlotinib combined with concurrent chemoradiotherapy in a patient with esophageal carcinoma.

Zhao CH, Liu RR, Lin L, Liu JZ, Ge FJ, Li SS, Ye CY, Chen YL, Wang Y, Xu JM. Zhao CH, et al. Int J Clin Exp Med. 2014 Nov 15;7(11):4492-7. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25550975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters